Compounds > tryptophan

tryptophan and Acute Promyelocytic Leukemia

tryptophan has been researched along with Acute Promyelocytic Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borutinskaite, VV; Navakauskiene, R; Savickiene, J; Treigyte, G1
Annicchiarico, MA; Cascino, A; Conversano, L; Mecarocci, S; Muscaritoli, M; Petti, MC; Rossi Fanelli, F; Torelli, GF1

Other Studies

2 other study(ies) available for tryptophan and Acute Promyelocytic Leukemia

ArticleYear
Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.
    Cellular & molecular biology letters, 2012, Volume: 17, Issue:4

    Topics: Acetylation; Cadherins; CD11b Antigen; Cell Differentiation; Cell Proliferation; CpG Islands; Cytidine; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Indoles; Leukemia, Promyelocytic, Acute; Methylation; Phthalimides; Promoter Regions, Genetic; Propionates; Tretinoin; Tryptophan

2012
Plasma amino acid concentrations in patients with acute myelogenous leukemia.
    Nutrition (Burbank, Los Angeles County, Calif.), 1999, Volume: 15, Issue:3

    Topics: Acute Disease; Adult; Aged; Case-Control Studies; Fatty Acids, Nonesterified; Female; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Prognosis; Remission Induction; Taurine; Tryptophan

1999